Home Mainline IPOs Gaudium IVF And Women Health IPO
Orion Industries logo

Gaudium IVF And Women Health IPO

Open MainLine
BSE,NSE 20 February - 24 February 2026
Gaudium IVF and Women Health Limited IPO is a book build issue of 165 Cr. The issue is a combination of fresh issue of 11392500 shares aggregating to 90 Cr and offer for sale of 9493700 shares aggregating to 75 Cr. Gaudium IVF and Women Health Limited IPO opened for subscription on Feb 20, 2026 and closed on Feb 24, 2026. The allotment for the this IPO was finalized on Feb 25, 2026. IPO was listed on NSE and BSE on Feb 27, 2026. Gaudium IVF and Women Health Limited IPO is set issue price band at ₹75 to ₹79 per share.

Current GMP

₹-4 (-5.06%)

Price Band

₹ 75 – 79

Lot Size

189

Issue Size

₹165 Cr

Minimum Investment

₹14931 (189 Shares)

Listing Date

27 February 2026

Subscription

7.27x

About the Company

Gaudium IVF & Women Health Limited is a pan-India fertility and women’s healthcare provider, incorporated in March 2015. The company delivers Assisted Reproductive Technology (ART) services through a scalable hub-and-spoke model, enabling operational efficiency and wider patient reach across India.

Gaudium IVF operates over 30 locations, including seven company-owned hub centres and 28 spoke centres developed through strategic alliances with leading infertility specialists. Its hubs are situated in key urban markets—two in Delhi (Janakpuri and Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bengaluru—ensuring strong geographic coverage and accessibility. The company also serves international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.

The company offers a comprehensive range of fertility treatments, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Frozen Embryo Transfer (FET), ovulation induction, fertility preservation through cryopreservation, and advanced genetic screening such as Preimplantation Genetic Testing (PGT). In addition to reproductive medicine, Gaudium provides integrated gynecological and obstetric services, including treatment for PCOD/PCOS, endometriosis management, high-risk pregnancy care, male infertility treatments, and minimally invasive laparoscopic and hysteroscopic procedures.

A key differentiator of the company is its holistic and patient-centric approach. Beyond clinical treatment, Gaudium IVF integrates fertility wellness programs that include nutritional counseling and psychological support to enhance patient outcomes. As of March 31, 2025, the company had a workforce of 124 employees, including seven consultancy doctors.

Competitive Strengths

  • Strong patient-centric care model
  • Experienced and specialized medical team
  • Advanced laboratory infrastructure, including next-generation INTEGRA Ti labs for ICSI
  • Highly technical ultrasound-guided (USG) services
  • Strategically located hubs in prime urban centres
  • Asset-light and scalable hub-and-spoke operating model

Overall, Gaudium IVF & Women Health Limited combines clinical expertise, advanced reproductive technologies, and a scalable business structure to strengthen its position in India’s growing fertility care market.

Promoters

  1. Dr. Manika Khanna
  2. Dr. Peeyush Khanna
  3. Vishad Khanna
Promoters Holding

Holding Pre Issue

99.99%

Holding Post Issue

71.30%

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.

  1. Funding capital expenditure towards establishment of New IVF Centers of our Company .                      : 50.00Cr
  2. Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company.           : 20.00Cr     
  3. General Corporate Purposes 

Address / Contact Info

Gaudium IVF & Women Health Limited

B1/51,Janak Puri,B-1,
New Delhi, New Delhi, 110058

Email:compliance@gaudiumivfcentre.com
Telephone: 011- 4885 8585.
Website:http://www.gaudiumivfcentre.com/

IPO Snapshot

Face Value₹5 per share
Price Band₹ 75 – 79
Lot Size189
Issue TypeBook-building IPO
Sale TypeFresh Capital & Offer For Sale
Fresh Issue₹ 90.00 Cr
Offer for Sale₹ 75.00 Cr
Total Issue Size₹ 165.00 Cr
Listing AtBSE,NSE
IndustryHealthcare Services
SectorHealthcare
QIB Quota28.57%
BNII Quota14.29%
SNII Quota7.14%
Retail Quota50%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Gaudium IVF And Women Health IPO is a Book-building IPO worth ₹165 crores. The price band is ₹75 to 79 per share. The IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026. It will be listed on BSE and NSE. Bigshare Services Pvt Ltd is the registrar.

The Gaudium IVF And Women Health IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026

Gaudium IVF And Women Health IPO Price Band is ₹75 to 79.

Gaudium IVF And Women Health IPO lot size is 189, and the minimum amount required for application is ₹14931.

The minimum investment for Gaudium IVF And Women Health IPO is approximately ₹14931 based on the upper price band.

To apply for the Gaudium IVF And Women Health IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Feb 24, 2026. After submission, funds are blocked until the basis of allotment of Gaudium IVF And Women Health IPO is finalised.

Gaudium IVF And Women Health IPO issue size is ₹165 crores.

Gaudium IVF And Women Health IPO allotment date is Sat, Jun 27, 2026.

The registrar for Gaudium IVF And Women Health IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Gaudium IVF And Women Health IPO through their official website or helpline.

The Gaudium IVF And Women Health IPO GMP (Grey Market Premium) is ₹0 as of Fri, Feb 27, 2026. Based on the upper price band of ₹79 per share, the estimated Gaudium IVF And Women Health IPO listing price is ₹79, indicating a potential listing gain of approximately 31% over the issue price.